World leaders have committed to the prevention and treatment of Alzheimer's Disease by 2025, but contemporary drug development is often slow. In this post, Dr.… Read more »
Dr. Cummings is Director of the Cleveland Clinic Lou Ruvo Center and the Camille and Larry Ruvo Chair for Brain Health. He is experienced in Alzheimer drug development and clinical trials for neurodegenerative disease and is co-chair of the Global Alzheimer's Platform Trial Network (GAP-NET). Dr. Cummings is also the lead author of Drug Development in Alzheimer’s Disease: the Path to 2025.
Latest posts by Dr. Jeffrey Cummings (see all)
- The road to 2025: will a treatment for Alzheimer’s be available? - 21st September 2016